Feasibility & Market Analysis
Empowering strategic decisions with real-world insights and market intelligence. "Optimize your launch strategies with data-driven market access solutions."
What We Offer
At ITROM, we recognize that a successful product launch starts with a deep understanding of the market landscape.
Our Feasibility and Market Access Studies provide comprehensive insights into healthcare ecosystems, regulatory environments, and competitive positioning — helping you make informed, strategic decisions before investing.
Whether you are expanding into MENA markets or evaluating a new molecule, we bring you actionable intelligence to minimize risk and maximize success.
What’s Included in This Service?
Feasibility Studies
Assessing product viability, regulatory hurdles, and potential barriers to entry.
Market Landscape Analysis
Detailed review of competitors, pricing benchmarks, payer expectations, and market dynamics.
Health Economics & Outcomes Research (HEOR)
Cost-effectiveness analyses and real-world evidence collection to support pricing and reimbursement strategies.
Stakeholder Mapping
Identification of key opinion leaders (KOLs), healthcare providers, payers, and regulatory stakeholders.
Access Strategy Development
Designing country-specific market entry strategies aligned with local healthcare frameworks.
Pricing & Reimbursement Strategy
Developing data-driven plans to optimize pricing and secure reimbursement.
Why It Matters
Entering a new market without a clear strategy leads to costly failures.
Our services ensure:
- Early identification of market opportunities and risks
- Improved budget planning for market launch
- Evidence-backed pricing and reimbursement pathways
- Increased acceptance among payers and regulators
Our Regional Expertise
- Specialized knowledge in UAE, Saudi Arabia, Egypt, and broader MENA regulations
- Access to real-time regional market data and industry reports
- Expertise across pharmaceuticals, biologics, medical devices, and nutraceuticals